Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 68Lung Neoplasms 12Adenocarcinoma 3Pancreatic Neoplasms 2Non-small-cell Lung Cancer With Somatic EGFR Mutations 2Neoplasms 2NSCLC 2Melanoma 2Colorectal Neoplasms 2Breast Neoplasms 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Squamous Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1NSCLC Harboring NRG1 Fusion 1

Interventions

tislelizumab 1Prednisone 1Carboplatin 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Squamous Non Small Cell Lung Cancer × Afatinib × Thoracic × Clear all
NCT04497584 2025-10-01

Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC

University of Texas Southwestern Medical Center

Phase 2 Active not recruiting
12 enrolled
Thoracic

Advanced Squamous Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡